- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01033162
Effectiveness of the CHESS eHealth Cancer Support Intervention in Population-based Care
Using Technology to Enhance Cancer Communication and Improve Clinical Outcome: Effectiveness of the CHESS Ehealth Cancer Support Intervention in Population-Based Care Study
The study's aim is to provide information about the clinical and business cases for comprehensive interactive cancer communication systems (ICCS) in the context of real world use for cancer care.
This study will be conducted within the Kaiser Permanente Northwest (KPNW) healthcare system. Outcomes for this study include amount of ICCS use and women's ratings of cancer information competence, perceived social support, and emotional well being. Secondary outcomes will include healthcare utilization, cost-effectiveness, and clinician ratings of healthcare visits.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Oregon
-
Portland, Oregon, United States, 97227
- Kaiser Permanente Northwest
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- All subjects must be within 2 months of their primary breast cancer diagnosis,
- All subjects must be at least 18 years of age
Exclusion Criteria:
- Illiterate
- Homeless
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Usual Care
A group using a Basic ICCS provided by KPNW
|
|
|
Experimental: Intervention
A group using an enhanced ICCS with KPNW web resources and the Comprehensive Health Enhancement Support System (CHESS.)
|
Half of the participating women will be randomly assigned to use an informative but static website (Basic ICCS), and half will be offered a fully interactive CHESS (Enhanced ICCS + the Basic ICCS). Study outcome data will be gathered from patients, clinicians, and the healthcare system (i.e., from the electronic medical record: EMR) for at least 8 months after study entry. We propose that the Enhanced ICCS relative to the Basic ICCS, will:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Amount of ICCS use and women's ratings of cancer information competence, perceived social support, and emotional well being. Secondary outcomes will include healthcare utilization, cost-effectiveness, and clinician ratings of healthcare visits.
Time Frame: 12 Months
|
12 Months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Timothy Baker, University of Wisconsin, Madison
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- H-2008-0222
- SMPH/MEDICINE/MEDICINE*G (Other Identifier: UW Madison)
- A534253 (Other Identifier: UW- Madison)
- 5P50CA095817 (U.S. NIH Grant/Contract)
- XP08323 (Other Identifier: University of Wisconsin Carbone Cancer Center)
- NCI-2013-01101 (Registry Identifier: NCI Trial ID)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Primary Breast Cancer
-
Nanfang Hospital, Southern Medical UniversityNot yet recruitingPrimary Breast CancerChina
-
Queen Mary University of LondonAstellas Pharma IncCompletedPrimary Breast Cancer ER+ve | Primary Breast Cancer AR+ve TNBNGermany, United Kingdom, Spain, United States, Ireland
-
Tomsk National Research Medical Center of the Russian...CompletedPrimary Breast CancerRussian Federation
-
Tomsk National Research Medical Center of the Russian...Uppsala University; Institute of Bioorganic Chemistry, Russian Academy of SciencesCompletedPrimary Breast CancerRussian Federation
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Hoffmann-La Roche; Brigham and Women's...TerminatedStage I Breast Cancer | Stage II Breast Cancer | Invasive Breast Carcinoma | Stage III Breast Cancer | Primary Invasive Breast CancerUnited States
-
University Health Network, TorontoCompletedBreast Cancer Invasive Nos | Primary Invasive Breast CancerCanada
-
RWTH Aachen UniversityRecruiting
-
Tao OUYANGPeking University First Hospital; 307 Hospital of PLA; Peking University People... and other collaboratorsActive, not recruiting
-
German Breast GroupCompleted
Clinical Trials on Enhanced ICCS with KPNW web resources and the Comprehensive Health Enhancement Support System (CHESS.)
-
University of Wisconsin, MadisonNational Cancer Institute (NCI)CompletedCHESS and Cancer Mentor | CHESS Only | Mentor Only | Control (Internet Only)United States